Patient Data
| Parameter | Group A (1 therapy) (n = 19) | Group B (2 therapies) (n = 19) | Group C (≥3 therapies) (n = 22) |
| Age at diagnosis (y) | |||
| Mean ± SEM | 62.3 ± 1.5 | 61.9 ± 1.8 | 64.0 ± 1.4 |
| Median | 64.1 | 61.7 | 62.6 |
| Range | 48.1–69.9 | 46.2–73.1 | 54.8–78.5 |
| P | 0.744 | ||
| Age at start of treatment (y) | |||
| Mean ± SEM | 69.7 ± 1.8 | 67.9 ± 1.9 | 69.6 ± 1.5 |
| Median | 70.8 | 67.7 | 67.2 |
| Range | 49.1–83.9 | 50.4–86.6 | 58.3–81.2 |
| P | 0.556 | ||
| Gleason score | |||
| 3 | 1 (5.9%) | — | — |
| 5 | 3 (17.6%) | 1 (5.2%) | — |
| 6 | — | 2 (10.5%) | 2 (9.5%) |
| 7 | 4 (23.5%) | 6 (31.6%) | 8 (38.1%) |
| 8 | 5 (29.4%) | 6 (31.6%) | 9 (42.9%) |
| 9 | 4 (23.5%) | 4 (21.1%) | 2 (9.5%) |
| Prognostic factor according to Helpap | |||
| Good (≤7) | 8 (47.1%) | 9 (47.4%) | 10 (47.6%) |
| Bad (8–10) | 9 (52.9%) | 10 (52.6%) | 11 (52.4%) |
| P | 0.999 |